News

​

Latest news

• NEAD group Christmas symposium about risk in psychiatry and clinical trials, December 2019
  

• Click here to read the Lundbeckfonden News article, "Topforsker - med baby på armen", which includes an interview with Professor Kamilla Miskowiak.
  
  

• Watch Dr Jeanett Bauer, assisting scientific editor on The Journal of the Danish Medical Association (Ugeskrift for Læger), highlight our recent review on cognitive side-effects of electroconvulsive therapy.
  
  https://vimeo.com/302033866
  
  Read the full article here (Danish language): https://www.ncbi.nlm.nih.gov/pubmed/29720345
  

• The International Society for Bipolar Disorders (ISBD) Targeting Cognition Task Force chaired by Professor Miskowiak has developed a patient booklet with information about the nature of cognitive dysfunction in patients with bipolar disorder and a practical guide on how to facilitate cognitive capacity and compensate for cognitive problems in daily life (https://www.isbd.org/cognitive-assessment).
  

  Click below to access the booklet and read more about why, when, and how to assess and address cognition in these patients.
  
  English version:
  

  
  

  Danish version:
  

• NEAD Group was well represented among poster presenters at the annual Psychiatric Research Day ("Region Hovedstadens Psykiatris Forskningsdag"), which took place at Rigshospitalet, Copenhagen,
  Denmark on the 27th of June 2018.
  

​In t​he ​news

Interna​tional and national media coverage of our research

• Professor Kamilla Woznica Miskowiak defended her doctoral dissertation and was awarded the doctoral degree in medical science (dr.med.) on Thursday 11th of January 2018. Click here to read more.

• European Psychiatric Association (EPA) 2017
  

• The impact and challenges of cognitive impairments - Interviews with Professor Kamilla Miskowiak. Clik here and watch the video interviews by clicking below:
  
  
• What impact do cognitive symptoms have on a patient’s ability to function and return to work?
  
  
• What are the most significant challenges in treating mood disorders? Can anything be done to smooth the return to work for people who are in recovery from MDD?
  

• Radio interview
  

• Dr Kamilla Miskowiak’s interview about electroconvulsive therapy and cognition on the national Danish radio, P1, 31st January 2017. Click here to listen to the broadcast.
  

November 2016

• Lundbeckfonden Fellowship
  

• Dr Kamilla Miskowiak is one of the new Lundbeckfonden Fellows 2016. The fellowship of 10 million DKK (1.34 million Euro) enables her to conduct a large neuroimaging project that aims to identify a novel brain-based biomarker model for pro-cognitive effects. A biomarker model that can help select among new candidate cognition treatments prior to large-scale clinical efficacy trials. The project may lead to a break-through in development of treatments for cognitive impairment in psychiatric disorders.
  
  See a 2 minute film about the project here:

​​​September 2016

• See the latest international news about our EPO research based on a poster that was presented at the European College of Neuropsychopharmacology (ECNP) meeting in Vienna Sep 2016:
  

EPO may improve cognition for depression, bipolar disorder patients (United Press International)

​

​Hormone EPO shown to improve brain sharpness in patients with depression and bipolar disorder​ (ScienceDaily)

Sports drug may aid cognition in depression, bipolar disorder (PsychCentral)

Per​formance boosting drug may help brain disorder patients (The Free Press Journal)

EPO boosts cognition in depressed and bipolar patients​ (Genetic Engineering & Biotechnology News)

Performance boosting hormone may help patients with mental disorders (Indo-Asian News Service)

Performance boosting drug may help brain disorder patients ​(Business Standard)

Hormone EPO shown to improve brain sharpness in patients with depression and bipolar disorder (MedicalXpress)

​Performance-enhancing drug may improve cognition in patients with bipolar disorder or depression (News-Medical)

EPO-Doping bei Depressionen​ (bild der wissenschaft)

July 2016

• Video podcast with Dr Kamilla Miskowiak telling about EPO-associated memory improvement in mood disorders (Acta Psychiatrica Scandinavica) 
  

Other news

Doping hormone helps depressed remember better​ (ScienceNordic) 
http://sciencenordic.com/doping-hormone-helps-depressed-remember-better 

NeuroScene podcast interview with Dr Kamilla Miskowiak: Erythropoietin: A New Compound for Depression?

http://www.stephenhernan.com/2011/02/25/neuroscene-kamilla-miskowiak-erythropoietin-a-new-compound-for-depression/

In Danish:

EPO giver depressive bedre hukommelse (Videnskab.dk)

http://videnskab.dk/krop-sundhed/epo-giver-depressive-bedre-hukommelse 

EPO ser ud til at have antidepressiv effekt​ (Videnskab.dk)

http://videnskab.dk/krop-sundhed/epo-ser-ud-til-have-antidepressiv-effekt 

Dopingmiddel kan hjælpe depressive (Information.dk)

https://www.information.dk/telegram/2013/12/dopingmiddel-kan-hjaelpe-depressive ​

EPO styrker hukommelsen hos mennesker med depression (Mental health services in the Capital Region of Denmark)

https://www.psykiatri-regionh.dk/presse-og-nyt/pressemeddelelser-og-nyheder/Nyheder-og-pressemeddelelser/Sider/epo-styrker-hukommelsen-hos-mennesker-med-depression.aspx 

Forskning i følelser vinder frem
(Interview with Dr Kamilla Miskowiak about emotion research in the national Danish newspaper Kristeligt Dagblad)

http://www.kristeligt-dagblad.dk/liv-sjael/forskning-i-foelelser-vinder-frem

Radio interview with Dr Kamilla Miskowiak in Danish about gender bias in science after she was given the L’Oréal For Women in Science award; fast forward to 31 minutes into the program

http://www.radio24syv.dk/programmer/weekendtillaegget/7657572/weekendtillgget-0805/​

​​